Invention Grant
- Patent Title: Arginine derivatives with NP-I antagonistic activity
- Patent Title (中): 具有NP-1拮抗活性的精氨酸衍生物
-
Application No.: US12439523Application Date: 2007-10-04
-
Publication No.: US08158789B2Publication Date: 2012-04-17
- Inventor: Haiyan Jia , Ian Zachary , Michelle Tickner , Lili Cheng , Chris Chapman , Katie Ellard , Basil Hartzoulakis , Ashley Jarvis , Rosemary Lynch , Jamie Nally , David Selwood , Mark Stewart
- Applicant: Haiyan Jia , Ian Zachary , Michelle Tickner , Lili Cheng , Chris Chapman , Katie Ellard , Basil Hartzoulakis , Ashley Jarvis , Rosemary Lynch , Jamie Nally , David Selwood , Mark Stewart
- Applicant Address: GB London
- Assignee: Ark Therapeutics Group Ltd.
- Current Assignee: Ark Therapeutics Group Ltd.
- Current Assignee Address: GB London
- Agency: Pharmaceutical Patent Attorneys, LLC
- Priority: GB0619611.7 20061004
- International Application: PCT/GB2007/003766 WO 20071004
- International Announcement: WO2008/040979 WO 20080410
- Main IPC: C07D409/14
- IPC: C07D409/14
Abstract:
The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
Public/Granted literature
- US20100022525A1 Arginine Derivatives with NP-I Antagonistic Activity Public/Granted day:2010-01-28
Information query
